TARA$2.44+1.04%
Protara Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$143.9M
Float & O/S:
Inst Own:
DilutionScan read 43 of Protara Therapeutics, Inc.'s SEC filings and found 3 warrant series, 1 convertible, 1 ATM program, 3 shelf registrations and 1 completed offering on file for TARA. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.